CIO

NOVEMBER 30, 2022

With the $5 billion biotech company expanding from R&D and manufacturing into clinical-based genomic health, Rollins sees IT playing an increasingly critical role in business growth and patient care. They adopt what is clearly becoming the gold standard of IT and business team integration: a capabilities (or product) management model.

Business 391

Business IT Biotech Knowledge 391

Netbasequid

FEBRUARY 22, 2021

Want to know how many biotech companies have received private funding over the last ten years? Search for biotech companies receiving private funding over the last ten years. From here, the biotech world is your oyster. The Quid product encourages a deep dive into insights uncovered through the power of visualized data.

Biotech 98

Biotech Innovation Intellectual Property Market Research 98

Alpha Sense BI

FEBRUARY 8, 2023

Specifically, within the pharma and biotech sectors, there have been 22 deals announced so far in 2023 — again, a low number compared to the 70 made over the same period last year. Additionally, unprofitable biopharma, aka most biotech companies, is expected to invest $1.1

Biotech 96

Biotech Research Innovation Capital 96

ArchIntel

MARCH 9, 2021

PharmaEssentia is looking for candidates with more than 10 years of experience in the pharma or biotech industry as a business insights, analytics and forecasting professional. The person selected for this position will be given the option to work remotely or join PharmaEssentia’s office in Burlington, Massachusetts.

Biotech 104

Biotech Pharmaceutical Travel Competitive Intelligence 104

SCIP

NOVEMBER 17, 2024

Generative AI in Healthcare and Biotech In healthcare and biotechnology, GenAI is advancing drug discovery, diagnostics, and personalized medicine. By simulating various design scenarios, GenAI accelerates the time it takes to bring new products to market, giving companies a competitive edge.

SCIP 40

SCIP Biotech Finance Innovation 40

Alpha Sense BI

JANUARY 25, 2023

Moderna and BioTech, the pharmaceuticals companies behind the Moderna vaccines for the COVID-19 virus, just announced a new treatment this past December that would greatly reduce the chances of death from melanoma — stirring up substantial interest in investors to funnel capital. a potential cure for skin cancer.

Biotech 96

Biotech Pharmaceutical Hospitals Market Intelligence 96

Zoominfo

APRIL 2, 2020

to discuss the future of one of the world’s largest biotech companies. On February 26, 175 executives gathered at the Marriott Long Wharf hotel in Boston, Mass., Within days, it was revealed that several of them were infected with COVID-19.

Biotech 100

Biotech Business Human Resources Technology 100

Alpha Sense BI

MARCH 26, 2025

With a 5,500 member R&D team and 14 research centers, Hengrui has positioned itself as a global leader in biotech innovation, making this one of the most significant healthcare IPOs in APACs 2025 market. LG Electronics India Industry : Consumer Electronics Expected Valuation : 15,000 crore ($1.8

Commerce 52

Commerce Pharmaceutical Capital Biotech 52

Evalueserve

DECEMBER 6, 2021

On the other hand, Biotech heavily underperformed post Q1’21 primarily due to the shifting of focus towards cyclicals and negative sentiments arising as of result of greater regulatory clampdown on transformative deals and drug pricing.

Capital 98

Capital Globalization Marketing Marketing 98

IT Business Edge

JULY 12, 2022

In January, the company announced $9 billion in new capital for venture opportunities, growth stage and biotech. Andreessen Horowitz certainly has lots of fire power for many more deals. Lightspeed. Lightspeed got its start at the depths of the dotcom bust – October 2000. But the timing would be propitious.

Startups 101

Startups Capital Biotech Finance 101

Sedulo

MARCH 15, 2023

Key Takeaways from the Assessment: While several insights were uncovered by analyzing trial clusters and the different IO drug modalities and sponsors, a few key takeaways from the data included: China emerging as innovation hub for IO therapies Smaller pharma/biotech conducting trials for emerging IO technologies Chinese and US small pharma/biotech (..)

Biotech 52

Biotech Competitive Landscape Pharmaceutical Benchmarking 52

Owler

MAY 17, 2023

Series A Funding Round Results in $59M for Taichu Biotech A China-based provider of drug development and evaluation services for the biopharmaceutical industry, Taichu Biotech raised $59M in funds. Plans for the funds include fortifying Ripplr’s tech platform for team expansion and building a pan-India presence. Everseen Raises $71.3M

Biotech 52

Biotech Travel Capital Entertainment 52

ArchIntel

JUNE 9, 2021

Earlier in his career, Fields worked as a conference and marketing coordinator at EBD Group, an organizer of biotech and medical device events. Fields briefly served as a consultant for the UCLA Anderson School of Management while already employed at the telco.

Competitive 104

Competitive Competitive Intelligence Biotech Profiling 104

Alpha Sense BI

MAY 5, 2023

Three years later, despite macroeconomic uncertainties, investors remain attracted to this space, particularly the more innovative and tech-influenced sub-sectors like biotech and MedTech. Many pharma companies with expiring patents are on the hunt to acquire biotech companies to address gaps in drug pipelines.

Biotech 97

Biotech Capital Banking Startups 97

Owler

JUNE 14, 2023

In Series A Funding Italy-based biotech company Aavantgarde Bio expressed that its initial focus following its successful funding round is to utilize the $65.3M The company automates home price estimate calculations using AI and manual assessments, allowing customers to sell their homes online and receive funds within 10 days.

Biotech 52

Biotech Startups Capital Research 52

Alpha Sense BI

AUGUST 30, 2023

Learn more about the AlphaSense impact by reading client success stories: DCAP Chooses AlphaSense for Faster, Deeper Searches—Saving Time and Money A fund with $50B in AUM starts all research with AlphaSense A biotech investor taps internal and external content for insights Get the Competitive Edge with AlphaSense AlphaSense is the leading market intelligence (..)

Management 98

Management Due Diligence Biotech Algorithm 98

Alpha Sense BI

MAY 28, 2024

The top three trending sectors—information technology, healthcare/biotech, and business and financial services— ushered in funding rounds over $100 million since the beginning of the year. While VC deals on the whole are down and hovering near historic lows, there is still notable activity—even some megadeals.

Capital 69

Capital Startups Due Diligence Biotech 69

Wink Intel

MARCH 29, 2021

Canadian firm buys Ohio National for $1 billion; Net income of life/annuity industry fell almost 50% in 2020; New index annuity income rider from AIG; SIMON adds First Trust Target Outcome ETFs; KKR, owner of Global Atlantic, reports earnings; Voya, Morningstar in managed accounts partnership; A ‘longevity’ biotech SPAC. .

Biotech 40

Biotech Globalization Management 40

Fuld

NOVEMBER 1, 2022

I plan to leverage that experience to help Fuld’s biotech and pharma clients successfully bring their own products to market. “Joining Fuld & Company is an exciting opportunity for me to work with global leaders in research, analytics, and intelligence ,” says Brad.

Pharmaceutical 52

Pharmaceutical Biotech Competitive Intelligence Competitive 52

BIS Research

MARCH 19, 2019

As it has successfully managed to bring together its different segments such as pharmaceutical & biotech, diagnostics, healthcare IT companies, care providers, hospitals, physicians and patients.

Globalization 64

Globalization Biotech Marketing Marketing 64

Alpha Sense BI

APRIL 29, 2024

The top three trending sectors—information technology, healthcare/biotech, and business and financial services—ushered in funding rounds over $100 million into 2024, providing optimism for a resurgence in deal activity. While VC deals on the whole are down and hovering near historic lows, there is still notable activity—even some megadeals.

Capital 52

Capital Due Diligence Biotech Startups 52

Alpha Sense BI

SEPTEMBER 1, 2023

The 10 initial drugs were chosen based on certain criteria set out by Medicare: they must be sold in pharmacies, not have substantial generic competition , and have been on the market for at least nine to 13 years for more complex biotech drugs. billion.

Pharmaceutical 52

Pharmaceutical Biotech Market Intelligence Competitive 52

Alpha Sense BI

JANUARY 26, 2024

This renewed interest in rare disease therapeutics can be attributed to the U.S.

Biotech 59

Biotech Research Loss Algorithm 59

Alpha Sense BI

APRIL 19, 2024

Quantum Computing is Generating Investor Buzz Like spatial computing, quantum computing is a relatively new term gaining traction with investors, venture capitalists, as well as biotech and healthcare startups, demonstrating a broad range of potential use cases —including financial modeling, weather forecasting, genome sequencing, drug discovery, cryptography, (..)

Technology 69

Technology Technology Retail Due Diligence 69

Alpha Sense BI

NOVEMBER 7, 2023

The 10 initial drugs were chosen based on certain criteria set out by Medicare: they must be sold in pharmacies, not have substantial generic competition , and need to have been on the market for at least nine to 13 years for more complex biotech drugs. So, how could this become a problem for pharma companies in future QoQs?

Pharmaceutical 52

Pharmaceutical Biotech Innovation Technology 52

Wink Intel

FEBRUARY 23, 2021

tech and biotech ETFs and two fixed income components. “By balancing risk and then seeking returns, this index aims to provide stable returns in many market environments.”. Credit Suisse Tech Edge Index (Ticker: CSEATEDG): The excess return index combines four U.S

Intellectual Property 40

Intellectual Property Banking Biotech Retail 40

Engage3

MAY 19, 2022

He has a wealth of cross-industry experience in accelerating companies’ growth and raising capital, having spent more than fifteen years in SaaS companies as CFO and COO in industries as varied as manufacturing and biotech. He holds B.A. degrees in Neuroscience and Behavior, Genetics, and Economics from Columbia University.

Retail 52

Retail Capital Finance Biotech 52

Alpha Sense BI

APRIL 12, 2024

For a healthcare engineer in the biotech engineering space, I’m gonna be really technical and get down to the nitty gritty behind the actual chemistry. You’re actually talking to the technologists, like the person building the code, the person selling the code, so you create different sets of questions depending on who the person is.” ”For

Primary Research 52

Primary Research Advantage Advantage Research 52

Alpha Sense BI

JUNE 6, 2024

Learn more about how AlphaSense supports corporations in creating and implementing their frameworks: Competitive Intelligence for Leading Corporations Competitive Intelligence in Healthcare Pharma & Biotech Competitive Intelligence Competitor Benchmarking Tool See how AlphaSense compares with other competitive intelligence platforms: 9 Competitive (..)

Competitor Analysis 40

Competitor Analysis Analysis Battlecard SWOT 40

Alpha Sense BI

NOVEMBER 9, 2022

M&A IPOs to watch in Pharma and Biotech. It’s going to help us to get it off the platform so that we could now invest in with the knowledge of what is working and replace those shows with content that has a chance to be more successful, have larger audiences, and we’re reallocating the capital.” – David M. JOYY Inc. [YY].

Sales 52

Sales Loss Capital Biotech 52

CIO

JULY 30, 2024

Some industries such as biotech are finding ways to use gen AI, but many enterprises experimenting with the technology have found a limited number of use cases so far, says Kjell Carlsson, head of AI strategy at Domino Data Lab, provider of an enterprise AI platform.

Biotech 542

Biotech Business Pharmaceutical Finance 542

CIO

JULY 17, 2023

It’s not only creating the vision but selling the vision,” says Joel Schwalbe, CIO of biotech company Transnetyx. “They need to create compelling rationalizations for IT investments through their storytelling. Tech governor in chief Such changes also will require CIOs to spend more time on governance, too, according to multiple sources.

Biotech 370

Biotech Innovation Research Technology 370

CIO

JANUARY 9, 2025

Jara, Chief Scientific Officer de Libelium; Alejandro Expsito, CIO y COO de la biotech Servatrix Biomed; y Zigor Gaubeca, CIO de Grupo Aire. Anticipamos un aumento en el nivel de inversin en el sector TI para 2025, explica Alejandro Expsito, CIO y COO de la biotech Servatrix Biomed. Se gastar ms en tecnologa?

Biotech 435

Biotech Globalization Learning IT 435

CIO

MARCH 4, 2025

Biotechnology and synthetic biology: The swift development of mRNA vaccines in 2020 illustrated biotechs unprecedented speed in delivering transformative products. Many Fortune 500 companies now invest in AI, robotics and biotech startups through corporate venture arms, gaining insights and strategic advantage.

Technology 444

Technology Technology Biotech Business 444

CIO

APRIL 3, 2025

At Biogen, she helped revolutionize the organizations digital capabilities in the highly regulated biotech industry. I think having experience across industries, from automotive to tech to biotech to utilities and now serving on boards, has given me an advantage. Its going to allow us to do more.

Biotech 430

Biotech IT Travel Win 430

Alpha Sense BI

MARCH 4, 2024

.” – Associate Director, Pharmaceutical Company | Expert Transcript Identifying Drug Targets and Candidates Traditional methods are mostly based on singular hypothesis-driven approaches and are limited by human capacity to analyze multi-dimensional data, which means they are prone to human error and bias.

Biotech 52

Biotech Pharmaceutical Intelligence Intelligence 52

CIO

NOVEMBER 25, 2024

I’ve had many great positions throughout my career, in many different industries, from biotech to pharma to tech software companies, and currently at a medical device company. So, it’s a little bit of yin and yang in my in my life, but I believe in data assurance. Then I started working.

Biotech 459

Biotech Matrix Learning Security 459